Skip to content

Stereotaxis STXS Change in AR

Change in AR at other companies

Abbott logo
AbbottABT
$42M-84.0%
Boston Scientific logo
Boston ScientificBSX
$117M+9.3%
Stryker logo
StrykerSYK
-$444M-208%
ITG
Integer HoldingsITGR
-$18.58M-202%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$3.58M-52.7%
iRadimed logo
iRadimedIRMD
-$212K-110%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's change in AR?
Stereotaxis (STXS) reported change in AR of -$543K in Q1 2026.
How has Stereotaxis's change in AR changed year-over-year?
Stereotaxis's change in AR decreased by 208.6% year-over-year, from $500K to -$543K.
What is the long-term trend for Stereotaxis's change in AR?
Over 2 years (2023 to 2025), Stereotaxis's change in AR has grown at a 26.3% compound annual growth rate (CAGR), from -$1.27M to $2.02M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.